CompletedNot Applicable

Research of Predictive Factors to Immune Thrombopenic Purpura

France37 participantsStarted 2013-01-15

Plain-language summary

It is about a multicentric study prospective of more than patients' 60 years with a thrombopenia isolated of less than 100 G/L blood platelet without cause found to estimate so certain examinations realized in the diagnosis (medullary cytogenetics, dosage of the TPO, the Anti-platelet antibodies, isotopic lifetime of platelet) are in favour of the diagnosis of PTI.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Rate of platelet \< 100 G/l for less than 12 months , * age = ou \> 60 years, * haemoglobin \> ou = 12 g / dl at the woman, \> ou = 13 g/dl at the man, * polymorphonuclear neutrophil \> ou = 1.7 G/l, * monocytes \< ou= 1 G/l, * lymphocytes \< ou = à 4 G/l, * VGM \< 100 fL, blood film normal, * informed consent, * expectation of life \> 6 months Exclusion Criteria: * hepatomegaly, * splenomegaly, * hepatic abnormality, * blood coagulation abnormality, * antecedent of auto-immune disease, * drug thrombopenia, * HIV, VHB or VHC positive, * antecedent of malicious tumor in the 5 years before inclusion

What they're measuring

the result of cytogenetics medullary

Timeframe: two years after inclusion

Trial details

NCT IDNCT01648556

SponsorCentre Hospitalier Universitaire, Amiens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-28

View on ClinicalTrials.gov More Purpura Thrombopenic trials